ANDA 204663, held by Zydus Pharms. Phentermine Hydrochloride.
As of Nov 16, 2026, ANDA 204663 (Phentermine Hydrochloride), held by Zydus Pharms, was first approved by FDA on Jun 28, 2017, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 28, 2017 | Original application | Approved |
| Phentermine Hydrochloride15MG · tablet, orally disintegrating;oral | Phentermine Hydrochloride | Rx |
| Phentermine Hydrochloride30MG · tablet, orally disintegrating;oral | Phentermine Hydrochloride | Rx |
| Phentermine Hydrochloride37.5MG · tablet, orally disintegrating;oral | Phentermine Hydrochloride | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters